The latest addition to its HD ultrasound family of products, the Philips HD7, has launched in the U.S. and is designed for high-volume use in cardiovascular, OB/GYN, anesthesiology, oncology, electrophysiology, stress echo, pediatric, orthopedic, urologic, emergency and other applications.

May 20, 2008 - Medtronic introduced Profile 3D Annuloplasty Ring with a design is based on the geometry of the saddle-shaped human mitral annulus to promote natural function with the aim of repairing rather than replacing a failing mitral valve.

The Profile 3D ring design is based data strongly suggesting that nature conserves the saddle-shaped annulus for a mechanical benefit. Specifically, leaflet stress can be related to saddle height, which could affect long-term durability of the repair.

May 20, 2008 - Boston Scientific launched its FilterWire EZ Embolic Protection System in a new 2.25 – 3.5 mm size, designed to contain and remove embolic material that may be dislodged during an interventional saphenous vein graft (SVG) procedure or material that travels into the microvasculature where it could pose an increased risk for a heart attack.

May 20, 2008 - Riata leads by St. Jude Medical showed very low adverse event rates for all categories of lead-related complications, with fracture rates of 0.09 percent, according to data collected from more than 680 physicians at more than 370 sites.

May 20, 2008 – Abbott launched the StarClose SE Vascular Closure System, a next-generation vessel closure device engineered to enable fast and secure closure of the femoral artery access site following a catheterization procedure.

May 20, 2008 — GE Healthcare is expanding its strategic alliance with Biosense Webster to develop real-time ultrasound imaging for use in electrophysiology procedures, enabling interventional procedures like ablation for arrythmia.

May 20, 2008 - Patient Care Technology Systems (PCTS) said today Providence Portland Medical Center (PPMC), Portland, OR has implemented Amelior ORTracker version 2.6 in its perioperative department.

May 20, 2008 - There were no device-related events at 30 days follow-up of the first 13 patients in the OPEN I clinical study using its bifurcated stent, according to the principal investigator who presented the report at the EuroPCR 2008 international medical meeting on cardiovascular intervention.

The data, presented by Eberhard Grube, M.D., chief of Cardiology and Angiology at HELIOS Heart Center (Germany) and principal investigator of the OPEN I study, included safety results after 30 days post-implantation of the Stentys bifurcated stent in the first 13 patients.

May 20, 2008 – Volcano paid $12 million in cash at the closing for the acquisition of Novelis Inc., a privately-held company that develops imaging products to use in crossing chronic total occlusions (CTOs), enabling Volcano to incorporate Novelis’ technology into its s5i integrated IVUS platform.

Under the terms of the agreement, Volcano paid approximately $12 million in cash at the closing and will may make an additional cash payment of $3 million based on the achievement of a specific regulatory milestone.

Boston Scientific launched its FilterWire EZ Embolic Protection System in a new 2.25 – 3.5 mm size, designed to contain and remove embolic material that may be dislodged during an interventional saphenous vein graft (SVG) procedure or material that travels into the microvasculature where it could pose an increased risk for a heart attack.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now